JP2006516140A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006516140A5 JP2006516140A5 JP2004563641A JP2004563641A JP2006516140A5 JP 2006516140 A5 JP2006516140 A5 JP 2006516140A5 JP 2004563641 A JP2004563641 A JP 2004563641A JP 2004563641 A JP2004563641 A JP 2004563641A JP 2006516140 A5 JP2006516140 A5 JP 2006516140A5
- Authority
- JP
- Japan
- Prior art keywords
- tested
- compounds
- found
- examples
- above assay
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000003556 assay Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43510202P | 2002-12-20 | 2002-12-20 | |
| PCT/US2003/040126 WO2004058148A2 (en) | 2002-12-20 | 2003-12-16 | Mitotic kinesin inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006516140A JP2006516140A (ja) | 2006-06-22 |
| JP2006516140A5 true JP2006516140A5 (enExample) | 2010-07-15 |
Family
ID=32682157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004563641A Ceased JP2006516140A (ja) | 2002-12-20 | 2003-12-16 | 有糸分裂キネシン阻害剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7622468B2 (enExample) |
| EP (1) | EP1581497A4 (enExample) |
| JP (1) | JP2006516140A (enExample) |
| AU (1) | AU2003297230B2 (enExample) |
| CA (1) | CA2509212A1 (enExample) |
| WO (1) | WO2004058148A2 (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004058700A2 (en) * | 2002-12-20 | 2004-07-15 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
| CA2527799A1 (en) * | 2003-05-30 | 2004-12-16 | Merck & Co., Inc. | Methods for identifying modulators of kinesin activity |
| ATE550019T1 (de) | 2005-05-17 | 2012-04-15 | Merck Sharp & Dohme | Cis-4-ä(4-chlorophenyl)sulfonylü-4-(2,5- difluorophenyl)cyclohexanepropansäure zur behandlug von krebs |
| GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| EP3536690A1 (en) | 2007-01-10 | 2019-09-11 | MSD Italia S.r.l. | Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors |
| KR20100072267A (ko) | 2007-10-19 | 2010-06-30 | 쉐링 코포레이션 | Ｋｓｐ 키네신 활성 억제용 스피로-축합된 1,3,4-티아디아졸 유도체 |
| WO2010114780A1 (en) | 2009-04-01 | 2010-10-07 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
| WO2011046771A1 (en) | 2009-10-14 | 2011-04-21 | Schering Corporation | SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF |
| US8999957B2 (en) | 2010-06-24 | 2015-04-07 | Merck Sharp & Dohme Corp. | Heterocyclic compounds as ERK inhibitors |
| AU2011285909B2 (en) | 2010-08-02 | 2016-11-10 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) |
| EP4079856A1 (en) | 2010-08-17 | 2022-10-26 | Sirna Therapeutics, Inc. | Rna interference mediated inhibition of hepatitis b virus (hbv) gene expression using short interfering nucleic acid (sina) |
| WO2012030685A2 (en) | 2010-09-01 | 2012-03-08 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
| EP3327125B1 (en) | 2010-10-29 | 2020-08-05 | Sirna Therapeutics, Inc. | Rna interference mediated inhibition of gene expression using short interfering nucleic acids (sina) |
| US9351965B2 (en) | 2010-12-21 | 2016-05-31 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as ERK inhibitors |
| EP2770987B1 (en) | 2011-10-27 | 2018-04-04 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
| EP3453762B1 (en) | 2012-05-02 | 2021-04-21 | Sirna Therapeutics, Inc. | Short interfering nucleic acid (sina) compositions |
| AU2013323508B2 (en) | 2012-09-28 | 2017-11-02 | Merck Sharp & Dohme Corp. | Novel compounds that are ERK inhibitors |
| CN103804283B (zh) * | 2012-11-06 | 2016-04-20 | 中国科学院大连化学物理研究所 | 一种制备1,2-二氢吡啶衍生物的方法 |
| EP2925888B1 (en) | 2012-11-28 | 2017-10-25 | Merck Sharp & Dohme Corp. | Compositions and methods for treating cancer |
| CA2895504A1 (en) | 2012-12-20 | 2014-06-26 | Merck Sharp & Dohme Corp. | Substituted imidazopyridines as hdm2 inhibitors |
| EP2951180B1 (en) | 2013-01-30 | 2018-05-02 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as hdm2 inhibitors |
| WO2015034925A1 (en) | 2013-09-03 | 2015-03-12 | Moderna Therapeutics, Inc. | Circular polynucleotides |
| CN104756984B (zh) * | 2015-03-30 | 2016-08-17 | 上海应用技术学院 | 多取代顺式二苯乙烯类化合物作为农用杀菌剂的应用 |
| JOP20190055A1 (ar) | 2016-09-26 | 2019-03-24 | Merck Sharp & Dohme | أجسام مضادة ضد cd27 |
| EP3525785B1 (en) | 2016-10-12 | 2025-08-27 | Merck Sharp & Dohme LLC | Kdm5 inhibitors |
| IL315837A (en) | 2017-04-13 | 2024-11-01 | Sairopa B V | Anti-SIRP-alpha antibodies |
| EP3706742B1 (en) | 2017-11-08 | 2023-03-15 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
| US11098059B2 (en) | 2017-11-08 | 2021-08-24 | Merck Sharp & Dohme Corp. | PRMT5 inhibitors |
| WO2019148412A1 (en) | 2018-02-01 | 2019-08-08 | Merck Sharp & Dohme Corp. | Anti-pd-1/lag3 bispecific antibodies |
| US11981701B2 (en) | 2018-08-07 | 2024-05-14 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
| WO2020033288A1 (en) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
| EP3833668B1 (en) | 2018-08-07 | 2025-03-19 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
| WO2021126729A1 (en) | 2019-12-17 | 2021-06-24 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
| WO2021126728A1 (en) | 2019-12-17 | 2021-06-24 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
| US20230108452A1 (en) | 2019-12-17 | 2023-04-06 | Merck Sharp & Dohme Llc | Prmt5 inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| EP0322034A3 (en) * | 1987-12-22 | 1991-01-02 | Merck Sharp & Dohme Ltd. | Methyl tetrahydropyridyl oxadiazoles |
| FR2662442A1 (fr) | 1990-05-23 | 1991-11-29 | Midy Spa | Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant. |
| EP0459568A3 (en) * | 1990-05-31 | 1992-09-30 | Merck Sharp & Dohme Ltd. | Substituted oxadiazoles and thiadiazoles for use in the treatment of glaucoma and novel compounds having such use |
| JP2000119250A (ja) * | 1998-08-11 | 2000-04-25 | Takeda Chem Ind Ltd | 環状アミド化合物、その製造法、中間体及び除草剤 |
| PL374190A1 (en) | 2002-06-14 | 2005-10-03 | Merck & Co, Inc. | Mitotic kinesin inhibitors |
| CA2500848A1 (en) * | 2002-10-18 | 2004-05-06 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
| WO2004058700A2 (en) * | 2002-12-20 | 2004-07-15 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
-
2003
- 2003-12-16 CA CA002509212A patent/CA2509212A1/en not_active Abandoned
- 2003-12-16 AU AU2003297230A patent/AU2003297230B2/en not_active Ceased
- 2003-12-16 US US10/539,531 patent/US7622468B2/en not_active Expired - Fee Related
- 2003-12-16 JP JP2004563641A patent/JP2006516140A/ja not_active Ceased
- 2003-12-16 WO PCT/US2003/040126 patent/WO2004058148A2/en not_active Ceased
- 2003-12-16 EP EP03814073A patent/EP1581497A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006516140A5 (enExample) | ||
| CY2024006I2 (el) | Διαμινοπυριμιδινες ως ρ2χ3 και ρ2χ2/3 ανταγωνιστες | |
| CY2019029I2 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις | |
| JP2004502858A5 (enExample) | ||
| EP1693005A4 (en) | ULTRASONIC UNIT AND ULTRASOUND SURVEY | |
| IL229509A0 (en) | Preparations containing chemically modified small molecules and processes using them | |
| DE60138711D1 (de) | Antikörper gegen il-12, zusammensetzungen, verfahren und verwendungen | |
| PT3718564T (pt) | Novos anticorpos anti-il 13 e suas utilizações | |
| EP1762234A4 (en) | AMPK AKTIVATOR | |
| DK1697378T3 (da) | Indoler, 1H-indazoler, 1,2-benzisoxazoler og 1,2-benzisothiazoler og fremstilling og anvendelser deraf | |
| ITMI20031127A0 (it) | Anticorpi anti-hgf e loro uso | |
| EP2302383A3 (en) | Docetaxel conjugates and immunogens for use in an immunoassay | |
| AU2003900878A0 (en) | Improved sodar sounding in the lower atmosphere | |
| EP1963840A4 (en) | IMMUNOASSAY DEVICE AND KIT | |
| NO20013352D0 (no) | Anordning for sortering av marine organismer | |
| DE502004001120D1 (de) | Sensorbauteil und nutzen zu seiner herstellung | |
| EP1682088A4 (en) | ORAL MICROEMULSION COMPOSITION WITH BIPHENYLDIMETHYLDICARBOXYLATE AND SILYBIN | |
| GB0308829D0 (en) | Assay methods and materials | |
| RU2004132147A (ru) | Адаптоген | |
| FR2862383B1 (fr) | Sonde d'incidence | |
| ITMO20040195A1 (it) | 'kit per la raccolta e la collezione di figurine'. | |
| IL157586A0 (en) | Diagnostic compositions containing an antibody to a beta-arrestin, methods utilizing the same and kits containing the same | |
| TW563863U (en) | Imitated insect specimen structure | |
| ITMI20021059A1 (it) | Aspiratore previsto in particolare per l'utilizzazione in officine o simili | |
| TH70139S (th) | ภาชนะบรรจุแบตเตอรี่แห้ง |